Featured

Aditum Bio Announces Formation of Third Company, Anteris Bio Anteris Bio Aimed at Treating Renal Diseases

FDA grants IO Biotech products breakthrough therapy designation

Massachusetts Biotech Council President and CEO Robert Coughlin to Step Down

AstraZeneca to Acquire Alexion

Life Sciences Boom: With 85 Active Life Science Tenants Requiring 3.9 Million SF, Greater Boston Life Sciences Market is Hot

Harrison Street and Partners Sell Three Life Sciences Properties in Cambridge Discovery Park for $720 Million

Trailblazers: Vertex CEO Reshma Kewalramani on Leadership, STEM, Diversity, Inclusion and Medicine on Chai With Manju

US Venture Capital Funding Rose by 33% During the COVID Pandemic; Only Life Sciences and Pharmaceuticals Witnessed Growth

Faze Medicines Launches With $81 Million Series A Financing to Leverage New Biology of Biomolecular Condensates to Treat Disease

Resolve Biosciences Launches New Era in Single-Cell Spatial Analysis